Latest Minimaze procedure Stories
SACRAMENTO, Calif., Feb. 7, 2012 /PRNewswire/ -- Sutter Medical Center, Sacramento became the second cardiac care center in the nation and the first in California to receive full Atrial Fibrillation Certification from the Society of Chest Pain Centers (SCPC). The announcement comes as the nation ushers in American Heart Month. Atrial fibrillation, or A-Fib, is the most common cardiac arrhythmia that can lead to stroke and possibly death. Nearly 3 million patients in the United...
MORRISVILLE, N.C., Jan. 9, 2012 /PRNewswire/ -- nContact, Inc., the leading innovator in epicardial ablation devices, today announced its technology will be presented by physicians in two posters at the 17th Annual International Boston Atrial Fibrillation Symposium, January 12-14 in Boston, Massachusetts. nContact will be showcasing its Numeris® Coagulation System with VisiTrax® and next generation EPi-Sense(TM) Coagulation System at its Boston AF Symposium booth #301....
MARLBOROUGH, Mass., Nov. 8, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that its HeartLight EAS will be discussed as a state-of-the-art technology and featured in a patient case presentation at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation, November 7-11, San Francisco, CA. TCT is the...
Despite significant improvements in stroke prevention over the past decade, and a fall in incidence and deaths, UK doctors are still undertreating one of the major risk factors - atrial fibrillation - reveals research published in BMJ Open. Atrial fibrillation, or AF for short, describes abnormal heart rhythms. Its treatment has been prioritized in the NHS in a bid to cut preventable deaths and disability from stroke. The researchers base their findings on an analysis of stroke data...
MARLBOROUGH, Mass., Aug. 22, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announces that the HeartLight EAS is now available in the United Kingdom. The first AF patients were treated at The Heart Hospital in London on Wednesday, August 17, with additional cases to take place throughout the month. The procedures were performed by Drs. Edward Rowland and Oliver Segal, consultant...
MARLBOROUGH, Mass., June 29, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today that its technology was featured in a live case and scientific abstract presented at the European Heart Rhythm Association (EHRA) EUROPACE 2011 congress on June 28 in Madrid, Spain. The case, "Atrial fibrillation ablation using laser balloon technology," demonstrated successful isolation of all...
Doctors at Washington University School of Medicine in St. Louis are performing a new procedure to treat atrial fibrillation, a common irregular heartbeat.Available at only a handful of U.S. medical centers, this "hybrid" procedure combines minimally invasive surgical techniques with the latest advances in catheter ablation, a technique that applies scars to the heart's inner surface to block signals causing the heart to misfire. The two-pronged approach gives doctors access to both the...
MARLBOROUGH, Mass., June 22, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight(TM) Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced today that its technology will be the subject of several scientific sessions at the upcoming European Heart Rhythm Association (EHRA) EUROPACE 2011 congress, June 26-29 in Madrid, Spain. HeartLight EAS is a unique catheter ablation technology that incorporates an endoscope and illumination to provide...
MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- CardioFocus, Inc., developer of the Endoscopic Ablation System for the transcatheter treatment of Atrial Fibrillation (AF), convened international leaders in electrophysiology to discuss the advantages of direct optical visualization to guide catheter ablation for the treatment of paroxysmal AF. The event followed the first day of the German Society for Cardiology Annual Meeting in Mannheim, Germany. The symposium, "Does Optical...
ROYAL OAK, Mich., March 4, 2011 /PRNewswire/ -- Doctors at Beaumont Hospital, Troy have performed Michigan's first minimally invasive robotic procedure to correct atrial fibrillation, a prevalent and growing heart rhythm disorder. The new robotic maze procedure is an alternative to open-heart surgery. It's performed through tiny, keyhole incisions with fewer complications and a shorter hospital stay. Phillip Robinson, M.D., cardiovascular surgeon, Brian Williamson, M.D. and Ilana Kutinsky,...
